Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at sorafenib after surgery for kidney cancer that had not spread (SORCE)

Overview

Cancer types:

Kidney cancer, Renal cell cancer

Status:

Results

Phase:

Phase 3

Details

This trial compared sorafenib with a dummy tablet (placebo) after surgery for renal cell cancer (kidney cancer) that had not spread. It was supported by Cancer Research UK.

The trial was open for people to join between 2007 and 2013, and the team published the results in 2020.

Recruitment start: 26 July 2007

Recruitment end: 12 April 2013

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Tim Eisen

Supported by

Bayer

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Medical Research Council (MRC)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/06/004.

Last reviewed: 10 December 2020

CRUK internal database number: 710

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.